Back

Repolarization and depolarization abnormalities are preferentially impaired by ajmaline in Brugada patients compared to controls

31 March 2025 (16:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Ventricular arrhythmias management Clinical EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Andrea Rossi

G. Monasterio CNR-RT Foundation, Pisa (Italy)

6 More presentations in this session

Presentation thumbnail
Single-center experience with quinidine for patients with electrical storm due to ventricular arrhythmias associated with short-coupled premature ventricular contractions
Doctor M. Negreira-Caamano (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Electroanatomical differences in ajmaline-induced compared to spontaneous type-1 Brugada phenotype
Doctor S. Latrofa (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Electrical storm in patients with hypertrophic cardiomyopathy
Doctor P. Groussin (FR)
Abstract Slides Video
Presentation thumbnail
Three-dimensional characterization of ventricular arrhythmias in structural heart disease with a novel digital twin framework.
Doctor M. Parollo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
A hybrid score to predict the origin of outflow tract ventricular arrhythmias in patients with intraventricular conduction disorders or paced rhythm
Doctor G. Falasconi (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular arrhythmias management

The Event

Event poster

EHRA 2025

31 March 2025 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Repolarization gradient induces local depolarization abnormalities in Brugada Syndrome
thumbnail
Congress Presentation
High-density unipolar endocardial mapping before and after ajmaline challenge to assess transmural repolarization gradients in Brugada syndrome: comparison with controls.
thumbnail
Congress Presentation
Regional differences in the right ventricular activation and repolarization patterns between Brugada patients and controls

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources